Search

Your search keyword '"Yoshioka, Kentaro"' showing total 25 results

Search Constraints

Start Over You searched for: Author "Yoshioka, Kentaro" Remove constraint Author: "Yoshioka, Kentaro" Topic interferons Remove constraint Topic: interferons
25 results on '"Yoshioka, Kentaro"'

Search Results

1. Risk factors and clinical characteristics of the depressive state induced by pegylated interferon therapy in patients with hepatitis C virus infection: A prospective study.

2. Efficacy of interferon treatment for chronic hepatitis C predicted by feature subset selection and support vector machine.

3. Mutations in carboxy-terminal part of E2 including PKR/eIF2alpha phosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b: their correlation with response to interferon monotherapy and viral load.

4. Mutations in the nonstructural region 5B of hepatitis C virus genotype 1b: their relation to viral load, response to interferon, and the nonstructural region 5A.

5. Ribavirin and use of clotting factors in patients with hemophilia and chronic hepatitis C.

6. Interferon therapy for aged patients with chronic hepatitis C: improved survival in patients exhibiting a biochemical response.

7. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy.

8. Amino acid substitutions in the nonstructural region 5A of hepatitis C virus genotypes 2a and 2b and its relation to viral load and response to interferon.

9. Daclatasvir and asunaprevir treatment in patients with severe liver fibrosis by hepatitis C virus genotype 1b infection: Real-world data.

10. The clinical features of patients with a Y93H variant of hepatitis C virus detected by a PCR invader assay.

11. Association of interleukin 28 B polymorphism and mutations in the NS5A region of hepatitis C virus genotype 2 with interferon responsiveness.

12. Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C.

13. Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C.

14. Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C.

15. Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan.

16. Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan.

17. Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study.

18. Efficacy of ribavirin plus interferon-α in patients aged ≥60 years with chronic hepatitis C.

19. The fluctuations of viral load and serum alanine aminotransferase levels in chronic hepatitis C

20. Mutations in Interferon Sensitivity- Determining Region of Hepatitis C Virus: Its Relation to Change in Viral Load.

21. Randomized Controlled Trial of Lymphoblastoid Interferon α for Chronic Hepatitis C (Comparison of 9-MU and 6-MU Doses).

22. Serial Quantitation of Serum Core Protein and Viral RNA of Hepatitis C Virus after Interferon Therapy: Increase in Viral Loads in Biochemical Responders.

23. Recombinant Human α-Interferon Therapy for Chronic Non-A, Non-B Hepatitis: Second Report.

24. Pilot Study of Recombinant Human α-Interferon for Chronic Non-A, Non-B Hepatitis.

25. Editorial: comorbidities, concomitant medications, and potential drug‐drug interactions with interferon‐free direct‐acting anti‐viral agents in chronic hepatitis C.

Catalog

Books, media, physical & digital resources